Eftilagimod Alfa
Eftilagimod Alfa Uses, Dosage, Side Effects, Food Interaction and all others data.
Eftilagimod Alfa is under investigation in clinical trial NCT02614833 (IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma).
Trade Name | Eftilagimod Alfa |
Generic | Eftilagimod alfa |
Eftilagimod alfa Other Names | Eftilagimod alfa, Immufact |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Eftilagimod Alfa